How to Choose a GLP-1 Provider in 2026: Safety Checklist for Men

Not all telehealth GLP-1 providers are created equal. The FDA sent warning letters to 30 companies in March 2026 alone. Here's how to vet yours.

Why Provider Selection Matters More Than Ever

The GLP-1 telehealth space exploded during the 2022-2024 drug shortages, and not all companies that entered the market operate with the same standards. In March 2026, the FDA issued warning letters to 30 telehealth firms for misleading marketing of compounded GLP-1 medications. Some were making unsubstantiated safety claims, while others were using deceptive pricing practices.

Your provider choice affects medication quality, medical oversight, pricing transparency, and what happens when regulations change. Here's how to evaluate them.

The Safety Checklist

1. Pharmacy Type and Licensing

The pharmacy fulfilling your prescription determines medication quality:

Pharmacy Type	What It Means	FDA Oversight
503B Outsourcing Facility	Large-scale compounding, FDA-registered, cGMP standards	Direct FDA oversight and inspection
503A State-Licensed	Traditional pharmacy, patient-specific prescriptions	State board oversight primarily
Brand-Name Only	Dispenses FDA-approved Wegovy, Zepbound, etc.	Full FDA drug approval pathway

None of these is inherently "bad" — but you should know which type your provider uses and what that means for your medication.

2. LegitScript Certification

LegitScript is an independent verification service that certifies healthcare merchants meet regulatory and safety standards. Providers with LegitScript certification have undergone vetting of their pharmacy relationships, marketing practices, and operational compliance.

Not all legitimate providers have LegitScript (it's voluntary), but its presence is a strong positive signal.

3. Actual Provider Consultation

A legitimate telehealth GLP-1 program includes:

• Licensed medical provider review — not just an automated questionnaire
• Medical history evaluation — including contraindications, current medications, and health conditions
• BMI eligibility criteria — typically BMI ≥30, or ≥27 with a weight-related condition
• Ongoing monitoring — follow-up check-ins, not just a prescription and disappearance

4. Pricing Transparency

Look for clear, upfront pricing that includes:

• Monthly medication cost at each dose level
• Whether membership or consultation fees are separate
• What happens to pricing at higher doses (some providers charge significantly more at 5mg+ semaglutide)
• Cancellation and refund policies

Provider Categories Worth Understanding

Brand-Name Prescribers

These providers prescribe FDA-approved medications like Wegovy and Zepbound. Higher per-unit cost but maximum regulatory certainty. Best for men with insurance coverage or who want the most established safety profile.

Compounded Medication Providers

These providers connect you with licensed compounding pharmacies that produce semaglutide or tirzepatide. Lower cost but requires understanding the regulatory landscape — especially with the FDA's recent 503B Bulks List proposal.

Questions to Ask Before Signing Up

1. "What type of pharmacy fills your prescriptions — 503A, 503B, or retail?"
2. "What is my total monthly cost at every dose level?"
3. "Will I speak with a licensed provider before receiving a prescription?"
4. "What is your refund policy if the provider determines I'm not eligible?"
5. "How do you handle the current FDA regulatory changes around compounding?"

The Bottom Line

The GLP-1 market has more options and more risk than ever before. Spend 10 minutes vetting your provider upfront — check pharmacy type, look for transparent pricing, ensure real medical oversight, and understand how regulatory changes might affect your access. The cheapest option isn't always the best, and the most expensive isn't automatically the safest. Look for the one that's transparent about how it operates.